Neos Therapeutics, Inc. (NASDAQ:NEOS) last session’s volume of 352024 shares was higher than its average volume of 317120 shares. The stock, after opening at $2.07, hit $2.32 through the close by scoring 14.85%.

Neos Therapeutics, Inc. (NEOS) Analyst Opinion

Neos Therapeutics, Inc. is currently rated as outperform by 5 stock analysts, with the company still having around 6.41% shares outstanding that can be sold short legally. The value of their shares went down by -29.27% last month. Over the course of a year, the stock has grown by 40.61%. Financial analysts are becoming more bullish than ever, with the 4 analysts who cover the activities of NEOS advising investors to buy. Experts on Wall Street have set a price target of $10.8 for the stock. The decision was arrived after looking at their 365.52% gain from current levels. At the moment, Neos Therapeutics, Inc. (NEOS) trading price is around -73.33% below its 52-week high.

Neos Therapeutics, Inc. Earnings Surprise

Neos Therapeutics, Inc. (NEOS) was successful in overcoming the expected -$0.28 as the stock recorded an earnings of -$0.23 a piece during their last financial report presentation. Revenue, meanwhile, had a distance of 17.12% from the previous quarter, with the company recording $14.64 million in revenue.

Neos Therapeutics, Inc. (NASDAQ:NEOS) Intraday View

The shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) have struggled and recovered 65.71% ever since it recorded its 52 week low. During the course of 5 days, the stock price volatility has remained at 9.35%, increasing the time frame to a month, the volatility recorded was 9.04%. The price of their shares still hasn’t been successful in staying above its 20 day-moving average, staying at a distance of -3.77% and while its 50-day moving average is around -4.37%. In a look at the previous five trading session NEOS stock has returned 13.17% and sank -33.66% when compared to its 200-day moving average that is $2.4846. Neos Therapeutics, Inc. (NEOS) will look to overcome its -71.71% fall that it witnessed in the past year.

As the normal trading session ended, the stock of Tilly’s, Inc. (NYSE:TLYS), fetched in a $0.66 spike to $11.77. The session began with the stock price at $11.19, hitting a high of $11.9 before down again. For the week, analysts seem to be okay with their bullish with the consensus call staying at 1.4. Tilly’s, Inc. gets 3 buy analyst recommendations while 0 recommend a hold and 0 rated it as a sell. The shares of the company tumbled -49.87% from its high $23.48, with their overall market value now roughly $343.21 million.

Tilly’s, Inc. (TLYS) Consensus Price Target

The mean recommendation of TLYS on Reuter’s scale remained unchanged from 1.4 to 1.4 within 30 days. This figure implies that the majority of analysts rate it as a buy. The price target for Tilly’s, Inc. (NYSE:TLYS) is now around $15.25 a share, implying the stock has what it takes to grow by 29.57%. The recent trading session also indicated the stock needs to add 52.93% more meet analysts’ high consensus price target.

Tilly’s, Inc. (NYSE:TLYS) Intraday Trading

The current trading volume of the company was 427146 shares during the last session. That compares with the recent average volume of 322080 shares. By the end of the regular trading session, the price volatility over a 1-week span was 3.82 % while over a month it stood at 3.21%. The stock price of TLYS dropped to $11.13 during the day and at a certain time in 12 months it traded as low as $9.4. It has made a 25.25% recovery since its 52-week low point and has returned 17.53% year-to-date. [T3]